Cardiovascular DiseasesNCT00005216
Multicenter Study of Silent Myocardial Ischemia (MSSMI)
An observational study of Cardiovascular Diseases and Coronary Disease, run by University of Rochester.
Trial summary
To determine if silent myocardial ischemia was associated with an increased risk of cardiac mortality and morbidity during a one to three year follow-up in patients with coronary heart disease. Read more about this study
- Who is it for?
- Ages 0 to 100 years, men only
- Conditions the study is for
- Cardiovascular Diseases, Coronary Disease, Myocardial Ischemia
- How many people
- Not given
- Where
- No sites listed yet
- Study dates
- Apr 1988to Dec 1994
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 to 100 years
- Men only
- No healthy volunteers
- Child, Adult, Older adult
No eligibility criteria
About this study
To determine if silent myocardial ischemia was associated with an increased risk of cardiac mortality and morbidity during a one to three year follow-up in patients with coronary heart disease.
Read the detailed description
BACKGROUND:
Reports of unsuspected, frequent and prolonged episodes of asymptomatic ST depression (ASTD) raised important issues for the evaluation and treatment of coronary disease. The traditional role of angina as the best indicator of myocardial ischemia had to be reevaluated, since several studies had shown that ASTD was much more frequent than symptomatic ischemia in many patients with coronary disease. If ASTD reflected clinically meaningful ischemia, then overt angina represented only 25 percent of the total ischemic burden. Moreover, incomplete data suggested that an increased and clinically unsuspected risk might be conferred on a patient with frequent episodes of ASTD. In 1988, studies were already in progress to find the most effective drug for treating ASTD. If no increased risk was associated with asymptomatic myocardial ischemia, there was little value in pursuing further investigations into its detection and therapy. But if the risk was increased, the detection and treatment of asymptomatic as well as symptomatic myocardial ischemia might completely alter therapy and the outlook for patients with coronary disease. The information in 1988 on the increased risk of ASTD was unfortunately scattered and sparse.
DESIGN NARRATIVE:
A total of 973 patients were enrolled two to six months after hospitalization for an acute coronary event. Patients were derived from geographically dispersed centers to enhance generalization of the results to the overall population at risk. Ambulatory 24-hour Holter electrocardiographic recordings were used to evaluate the frequency, severity, and duration of asymptomatic ST depression (ASTD) as a marker of silent myocardial ischemia during usual daily activities. This information was analyzed in conjunction with ST segment depression on treadmill exercise, reversible myocardial perfusion defects on stress thallium testing, and a limited number of prespecified clinical parameters to assess the contribution which ASTD added to prognostic information from then current diagnostic techniques used to evaluate myocardial ischemia. Patients were seen by the study coordinator every four months during the first year, then every six months thereafter. At each visit the study coordinator interviewed patients to determine interim history, functional status symptoms, and drug usage. At the four month visit a second 24-hour Holter recording was obtained. At the 12-month visit and at study termination, 12-lead electrocardiograms were recorded and sent to the ECG Core Laboratory for analysis. Data analyses were used: to assess the predictive usefulness and independence of ASTD in ambulatory patients with established coronary heart disease; to evaluate the interactions and associations between the frequency, severity, and duration of ASTD and other measures of myocardial ischemia; to obtain insight into suspected vasoactive and increased myocardial oxygen consumption mechanisms of myocardial ischemia; to better understand the interrelationship between myocardial ischemia and ventricular arrhythmias as it related to subsequent cardiac mortality and morbidity.
The study was renewed in 1993 for one year in order to fully analyze the prospectively accumulated data on the 973 enrolled patients in the Multicenter Study of Silent Myocardial Ischemia (MSSMI). The primary goal was to determine the usefulness, or the lack thereof, of ambulatory electrocardiographic (AECG) monitoring for identifying coronary patients with jeopardized ischemic myocardium at risk for ischemic cardiac events. The aims of the study were: 1) to evaluate the reproducibility of then current methods for detecting ischemic-type changes (ST depression) on AECG; 2) to improve the accuracy and reliability of contemporary scanner-interactive methodology that had been utilized for identifying ischemic-type ST-segment changes on the AECG; 3) to complete the development on a new, innovative, and reproducible computer-based technique for automatic (operator-independent), quantitative identification of beat-to-beat ischemic-type ST depression on the MSSMI AECG tapes; 4) to evaluate the clinical utility of the improved and new ST-segment analytic techniques to identify coronary patients at risk for natural cardiac events (unstable angina, non-fatal myocardial infarction, and cardiac death) during two year follow-up in the overall MSSMI population, in selected subgroups (gender, age), and in prespecified high-risk ischemic subsets; and 5) to determine the optimal cost- effective strategy for sequencing the assessment of silent, jeopardized ischemic myocardium by clinical variables and non-invasive tests to identify coronary patients at risk for subsequent ischemic cardiac events. This research utilized statistical techniques for evaluating reproducibility of detecting ST depression on AECG (kappa statistics, analyses of variance, Cochran's Q-test), for determining ischemic risk factors for time-to-cardiac events (Cox regression analyses), and for cost-effectiveness analyses (receiver-operator characteristic curves).
Twenty-four clinical centers In United States, Canada, Israel, and Japan participated in the study. There were also an ECG Core Lab, an Exercise Core Lab, a Holter Core Lab, a Thallium Core Lab, and a Coordinating Center.
- Conditions
- Cardiovascular Diseases, Coronary Disease, Myocardial Ischemia, Heart Diseases, Myocardial Infarction, Angina, Unstable
- Medical subject headings
- Cardiovascular Diseases, Coronary Disease, Myocardial Ischemia, Heart Diseases, Myocardial Infarction, Angina, Unstable, Arrhythmias, Cardiac
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 May 2000 (estimated)
- Study startApr 1988
- Study completionDec 1994
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (14)Papers the sponsor has linked to this study.
- Other trials for Cardiovascular DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
Sponsor and investigators
- Lead sponsor
- University of Rochester
- Sponsor type
- University, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00005216
- Sponsor's protocol ID
- 1095
- Other IDs
- R01HL038702
- Status last verified
- Nov 2025
- First submitted
- 25 May 2000
- Last updated
- 10 Nov 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Publications
Moss AJ, Benhorin J. Prognosis and management after a first myocardial infarction. N Engl J Med. 1990 Mar 15;322(11):743-53. doi: 10.1056/NEJM199003153221107. No abstract available.
PubMed 2407955Bigger JT Jr, Hoover CA, Steinman RC, Rolnitzky LM, Fleiss JL. Autonomic nervous system activity during myocardial ischemia in man estimated by power spectral analysis of heart period variability. The Multicenter Study of Silent Myocardial Ischemia Investigators. Am J Cardiol. 1990 Aug 15;66(4):497-8. doi: 10.1016/0002-9149(90)90712-a. No abstract available.
PubMed 2201185Freedland KE, Carney RM, Krone RJ, Case NB, Case RB. Psychological determinants of anginal pain perception during exercise testing of stable patients after recovery from acute myocardial infarction or unstable angina pectoris. Am J Cardiol. 1996 Jan 1;77(1):1-4. doi: 10.1016/s0002-9149(97)89124-2.
PubMed 8540443Bodenheimer MM, Wackers FJ, Schwartz RG, Brown M. Prognostic significance of a fixed thallium defect one to six months after onset of acute myocardial infarction or unstable angina. Multicenter Myocardial Ischemia Research Group. Am J Cardiol. 1994 Dec 15;74(12):1196-200. doi: 10.1016/0002-9149(94)90547-9.
PubMed 7977089Krone RJ, Gregory JJ, Freedland KE, Kleiger RE, Wackers FJ, Bodenheimer MM, Benhorin J, Schwartz RG, Parker JO, Van Voorhees L, et al. Limited usefulness of exercise testing and thallium scintigraphy in evaluation of ambulatory patients several months after recovery from an acute coronary event: implications for management of stable coronary heart disease. Multicenter Myocardial Ischemia Research Group. J Am Coll Cardiol. 1994 Nov 1;24(5):1274-81. doi: 10.1016/0735-1097(94)90109-0.
PubMed 7930250Moss AJ, Goldstein RE, Hall WJ, Bigger JT Jr, Fleiss JL, Greenberg H, Bodenheimer M, Krone RJ, Marcus FI, Wackers FJ, et al. Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event. Multicenter Myocardial Ischemia Research Group. JAMA. 1993 May 12;269(18):2379-85.
PubMed 8479063Zareba W, Moss AJ, Raubertas RF. Risk of subsequent cardiac events in stable convalescing patients after first non-Q-wave and Q-wave myocardial infarction: the limited role of non-invasive testing. The Multicenter Myocardial Ischemia Research Group. Coron Artery Dis. 1994 Dec;5(12):1009-18. doi: 10.1097/00019501-199412000-00008.
PubMed 7728293Wackers FJ, Bodenheimer M, Fleiss JL, Brown M. Factors affecting uniformity in interpretation of planar thallium-201 imaging in a multicenter trial. The Multicenter Study on Silent Myocardial Ischemia (MSSMI) Thallium-201 Investigators. J Am Coll Cardiol. 1993 Apr;21(5):1064-74. doi: 10.1016/0735-1097(93)90226-q.
PubMed 8459059Moriel M, Benhorin J, Brown MW, Raubertas RF, Severski PK, Van Voohees L, Bodenheimer MM, Tzivoni D, Wackers FJ, Mass AJ. Detection and significance of myocardial ischemia in women versus men within six months of acute myocardial infarction or unstable angina. The Multicenter Myocardial Ischemia Research Group. Am J Cardiol. 1996 Apr 15;77(10):798-804. doi: 10.1016/s0002-9149(97)89172-2.
PubMed 8623730Goldstein RE, Andrews M, Hall WJ, Moss AJ. Marked reduction in long-term cardiac deaths with aspirin after a coronary event. Multicenter Myocardial Ischemia Research Group. J Am Coll Cardiol. 1996 Aug;28(2):326-30. doi: 10.1016/0735-1097(96)00150-7.
PubMed 8800105Narins CR, Zareba W, Moss AJ, Goldstein RE, Hall WJ. Clinical implications of silent versus symptomatic exercise-induced myocardial ischemia in patients with stable coronary disease. J Am Coll Cardiol. 1997 Mar 15;29(4):756-63. doi: 10.1016/s0735-1097(96)00585-2.
PubMed 9091521Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C. Differential effects of beta-blockers in patients after recovery from myocardial infarction and after recovery from unstable angina. Multicenter Myocardial Ischemia Research Group. Heart Vessels. 1997;Suppl 12:160-1.
PubMed 9476569Freedland KE, Nakamura Y, Carney RM, Case RB, Case NB, Kawai C, Krone RJ, Kato N, Kinoshita M. Angina pectoris after recovery from an acute coronary event--the role of psychological factors in Japanese vs North American patients. Jpn Circ J. 1997 Apr;61(4):299-307. doi: 10.1253/jcj.61.299.
PubMed 9152781Nakamura Y, Kawai C, Moss AJ, Raubertas RF, Brown MW, Kinoshita M, Sasayama S, Nonogi H, Omae T, Tamaki S, Fujita M, Tanaka N, Hosoda S, Inoue H, Sugimoto T, Iinuma H, Kato K, Tamaki N, Sugiura N. Comparison between Japan and North America in the post-hospital course after recovery from an acute coronary event. Int J Cardiol. 1996 Aug;55(3):245-54. doi: 10.1016/0167-5273(96)02701-5.
PubMed 8877424
Study at a glance
From the registry record, last updated by the sponsor on 10 Nov 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Multicenter Study of Silent Myocardial Ischemia (MSSMI)
- ClinicalTrials.gov ID
- NCT00005216
- Acronym / sponsor ID
- 1095
- Conditions
- Cardiovascular Diseases, Coronary Disease, Myocardial Ischemia, Heart Diseases, Myocardial Infarction, Angina, Unstable
- Study type
- Observational
- Recruitment status
- Completed
- Lead sponsor
- University of RochesterUniversity, hospital or other
- Collaborators
- National Heart, Lung, and Blood Institute (NHLBI)
- Study start
- Apr 1988
- Study completion
- Dec 1994
- First posted
- 26 May 2000 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To determine if silent myocardial ischemia was associated with an increased risk of cardiac mortality and morbidity during a one to three year follow-up in patients with coronary heart disease.
Detailed description
BACKGROUND:
Reports of unsuspected, frequent and prolonged episodes of asymptomatic ST depression (ASTD) raised important issues for the evaluation and treatment of coronary disease. The traditional role of angina as the best indicator of myocardial ischemia had to be reevaluated, since several studies had shown that ASTD was much more frequent than symptomatic ischemia in many patients with coronary disease. If ASTD reflected clinically meaningful ischemia, then overt angina represented only 25 percent of the total ischemic burden. Moreover, incomplete data suggested that an increased and clinically unsuspected risk might be conferred on a patient with frequent episodes of ASTD. In 1988, studies were already in progress to find the most effective drug for treating ASTD. If no increased risk was associated with asymptomatic myocardial ischemia, there was little value in pursuing further investigations into its detection and therapy. But if the risk was increased, the detection and treatment of asymptomatic as well as symptomatic myocardial ischemia might completely alter therapy and the outlook for patients with coronary disease. The information in 1988 on the increased risk of ASTD was unfortunately scattered and sparse.
DESIGN NARRATIVE:
A total of 973 patients were enrolled two to six months after hospitalization for an acute coronary event. Patients were derived from geographically dispersed centers to enhance generalization of the results to the overall population at risk. Ambulatory 24-hour Holter electrocardiographic recordings were used to evaluate the frequency, severity, and duration of asymptomatic ST depression (ASTD) as a marker of silent myocardial ischemia during usual daily activities. This information was analyzed in conjunction with ST segment depression on treadmill exercise, reversible myocardial perfusion defects on stress thallium testing, and a limited number of prespecified clinical parameters to assess the contribution which ASTD added to prognostic information from then current diagnostic techniques used to evaluate myocardial ischemia. Patients were seen by the study coordinator every four months during the first year, then every six months thereafter. At each visit the study coordinator interviewed patients to determine interim history, functional status symptoms, and drug usage. At the four month visit a second 24-hour Holter recording was obtained. At the 12-month visit and at study termination, 12-lead electrocardiograms were recorded and sent to the ECG Core Laboratory for analysis. Data analyses were used: to assess the predictive usefulness and independence of ASTD in ambulatory patients with established coronary heart disease; to evaluate the interactions and associations between the frequency, severity, and duration of ASTD and other measures of myocardial ischemia; to obtain insight into suspected vasoactive and increased myocardial oxygen consumption mechanisms of myocardial ischemia; to better understand the interrelationship between myocardial ischemia and ventricular arrhythmias as it related to subsequent cardiac mortality and morbidity.
The study was renewed in 1993 for one year in order to fully analyze the prospectively accumulated data on the 973 enrolled patients in the Multicenter Study of Silent Myocardial Ischemia (MSSMI). The primary goal was to determine the usefulness, or the lack thereof, of ambulatory electrocardiographic (AECG) monitoring for identifying coronary patients with jeopardized ischemic myocardium at risk for ischemic cardiac events. The aims of the study were: 1) to evaluate the reproducibility of then current methods for detecting ischemic-type changes (ST depression) on AECG; 2) to improve the accuracy and reliability of contemporary scanner-interactive methodology that had been utilized for identifying ischemic-type ST-segment changes on the AECG; 3) to complete the development on a new, innovative, and reproducible computer-based technique for automatic (operator-independent), quantitative identification of beat-to-beat ischemic-type ST depression on the MSSMI AECG tapes; 4) to evaluate the clinical utility of the improved and new ST-segment analytic techniques to identify coronary patients at risk for natural cardiac events (unstable angina, non-fatal myocardial infarction, and cardiac death) during two year follow-up in the overall MSSMI population, in selected subgroups (gender, age), and in prespecified high-risk ischemic subsets; and 5) to determine the optimal cost- effective strategy for sequencing the assessment of silent, jeopardized ischemic myocardium by clinical variables and non-invasive tests to identify coronary patients at risk for subsequent ischemic cardiac events. This research utilized statistical techniques for evaluating reproducibility of detecting ST depression on AECG (kappa statistics, analyses of variance, Cochran's Q-test), for determining ischemic risk factors for time-to-cardiac events (Cox regression analyses), and for cost-effectiveness analyses (receiver-operator characteristic curves).
Twenty-four clinical centers In United States, Canada, Israel, and Japan participated in the study. There were also an ECG Core Lab, an Exercise Core Lab, a Holter Core Lab, a Thallium Core Lab, and a Coordinating Center.
Study design
Who may qualify
- Ages
- 0 to 100 years
- Sex
- Male only
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Nov 2025.
- Background: PubMed 2407955Moss AJ, Benhorin J. Prognosis and management after a first myocardial infarction. N Engl J Med. 1990 Mar 15;322(11):743-53. doi: 10.1056/NEJM199003153221107. No abstract available.
- Background: PubMed 2201185Bigger JT Jr, Hoover CA, Steinman RC, Rolnitzky LM, Fleiss JL. Autonomic nervous system activity during myocardial ischemia in man estimated by power spectral analysis of heart period variability. The Multicenter Study of Silent Myocardial Ischemia Investigators. Am J Cardiol. 1990 Aug 15;66(4):497-8. doi: 10.1016/0002-9149(90)90712-a. No abstract available.
- Background: PubMed 8540443Freedland KE, Carney RM, Krone RJ, Case NB, Case RB. Psychological determinants of anginal pain perception during exercise testing of stable patients after recovery from acute myocardial infarction or unstable angina pectoris. Am J Cardiol. 1996 Jan 1;77(1):1-4. doi: 10.1016/s0002-9149(97)89124-2.
- Background: PubMed 7977089Bodenheimer MM, Wackers FJ, Schwartz RG, Brown M. Prognostic significance of a fixed thallium defect one to six months after onset of acute myocardial infarction or unstable angina. Multicenter Myocardial Ischemia Research Group. Am J Cardiol. 1994 Dec 15;74(12):1196-200. doi: 10.1016/0002-9149(94)90547-9.
- Background: PubMed 7930250Krone RJ, Gregory JJ, Freedland KE, Kleiger RE, Wackers FJ, Bodenheimer MM, Benhorin J, Schwartz RG, Parker JO, Van Voorhees L, et al. Limited usefulness of exercise testing and thallium scintigraphy in evaluation of ambulatory patients several months after recovery from an acute coronary event: implications for management of stable coronary heart disease. Multicenter Myocardial Ischemia Research Group. J Am Coll Cardiol. 1994 Nov 1;24(5):1274-81. doi: 10.1016/0735-1097(94)90109-0.
- Background: PubMed 8479063Moss AJ, Goldstein RE, Hall WJ, Bigger JT Jr, Fleiss JL, Greenberg H, Bodenheimer M, Krone RJ, Marcus FI, Wackers FJ, et al. Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event. Multicenter Myocardial Ischemia Research Group. JAMA. 1993 May 12;269(18):2379-85.
- Background: PubMed 7728293Zareba W, Moss AJ, Raubertas RF. Risk of subsequent cardiac events in stable convalescing patients after first non-Q-wave and Q-wave myocardial infarction: the limited role of non-invasive testing. The Multicenter Myocardial Ischemia Research Group. Coron Artery Dis. 1994 Dec;5(12):1009-18. doi: 10.1097/00019501-199412000-00008.
- Background: PubMed 8459059Wackers FJ, Bodenheimer M, Fleiss JL, Brown M. Factors affecting uniformity in interpretation of planar thallium-201 imaging in a multicenter trial. The Multicenter Study on Silent Myocardial Ischemia (MSSMI) Thallium-201 Investigators. J Am Coll Cardiol. 1993 Apr;21(5):1064-74. doi: 10.1016/0735-1097(93)90226-q.
- Background: PubMed 8623730Moriel M, Benhorin J, Brown MW, Raubertas RF, Severski PK, Van Voohees L, Bodenheimer MM, Tzivoni D, Wackers FJ, Mass AJ. Detection and significance of myocardial ischemia in women versus men within six months of acute myocardial infarction or unstable angina. The Multicenter Myocardial Ischemia Research Group. Am J Cardiol. 1996 Apr 15;77(10):798-804. doi: 10.1016/s0002-9149(97)89172-2.
- Background: PubMed 8800105Goldstein RE, Andrews M, Hall WJ, Moss AJ. Marked reduction in long-term cardiac deaths with aspirin after a coronary event. Multicenter Myocardial Ischemia Research Group. J Am Coll Cardiol. 1996 Aug;28(2):326-30. doi: 10.1016/0735-1097(96)00150-7.
- Background: PubMed 9091521Narins CR, Zareba W, Moss AJ, Goldstein RE, Hall WJ. Clinical implications of silent versus symptomatic exercise-induced myocardial ischemia in patients with stable coronary disease. J Am Coll Cardiol. 1997 Mar 15;29(4):756-63. doi: 10.1016/s0735-1097(96)00585-2.
- Background: PubMed 9476569Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C. Differential effects of beta-blockers in patients after recovery from myocardial infarction and after recovery from unstable angina. Multicenter Myocardial Ischemia Research Group. Heart Vessels. 1997;Suppl 12:160-1.
Related trials for Cardiovascular Diseases
Active, not recruitingObservational study
Epidemiology of Sleep-Disordered Breathing in Adults
Sleep Disorders, Cerebrovascular Disorders
Active, not recruitingObservational study
Gulf Long-Term Follow-Up Study
Cardiovascular Disease, Hematologic Diseases
RecruitingObservational study
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Adrenal Gland Neoplasm, Hypertension
Recruiting
Ambient Air and Noise Effect on Cardiovascular Health Risk and Lifestyle Intervention to Attenuate It (METSGREEN)
Cardiovascular Diseases (CVD), Metabolic Syndrome
Recruiting
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
Cardiovascular Diseases, Myocardial Ischemia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
An observational study of Cardiovascular Diseases and Coronary Disease, run by University of Rochester.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 10 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00005216, which also lists 14 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Nov 2025; AzTrials last refreshed its copy on 26 Oct 2026.